Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|7|5|442-453

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.5, 2008-11, pp. : 442-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunocytochemical Characterization of Delta-Opioid and Mu-Opioid Receptor Protein in the Bovine Pineal Gland

By  

Cells Tissues Organs, Vol. 182, Iss. 1, 2006-04 ,pp. : 48-56

Karger

Access to resources Recommend Favorite

Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-04 ,pp. : 440-449

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid Receptor Antagonists in Psychiatry: Beyond Drug Addiction

By Rénéric J-P.   Bouvard M.P.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 365-382

Adis International

Access to resources Recommend Favorite

Drug dependence and the endogenous opioid system

By Gerrits M.A.F.M.   Lesscher H.B.M.   van Ree J.M.  

European Neuropsychopharmacology, Vol. 13, Iss. 6, 2003-12 ,pp. : 424-434

Elsevier

Access to resources Recommend Favorite

A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

By Kim Sung-Gon  

Psychopharmacology, Vol. 201, Iss. 4, 2009-01 ,pp. : 611-618

Springer Publishing Company

Access to resources Recommend Favorite